Of them, several genes have been reported to present prognostic value for CRC patients, such as CDX2 [19], EPHA2 [20], SLC2A1 [21], CDKN2A [22] and ITGA3 [23]. This evidence concerns the gene SLC2A1 and colorectal carcinoma.